SavedAdd your journal

Journals / Online Türk Sağlık Bilimleri Dergisi / 2026 / Cilt: 5 Sayı: 1

Autoimmune Hemolytic Anemia Developing Secondary to Epstein-Barr Virus Infection: A case report

Nevin İnce(DUZCE UNIVERSITY)0000-0002-0129-4536
Elif Çelik(DUZCE UNIVERSITY)0000-0003-2871-8156
Birgül Öneç(DUZCE UNIVERSITY)0000-0003-2824-1044
Hilal Şöhret Uyanık(DUZCE UNIVERSITY)0000-0002-7410-633X
Pages
199–202
Publication Date
2020-03-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We describe a young patient developing hemolytic anemia during follow-up in our clinic due to tonsillopharyngitis secondary to EBV and general condition disorder.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Infectious mononucleosis (EM) is a disease characterized by irradiation of the Epstein-Barr virus (EBV).
📊
Key Findings & Data:The clinical manifestation is characterized by tonsillopharyngitis, lym-phadenopathy and atypical lymphocytosis.
💡
Conclusion & Impact:We describe a young patient developing hemolytic anemia during follow-up in our clinic due to tonsillopharyngitis secondary to EBV and general condition disorder.
🔬Design:Olgu Sunumu
📍Scope:Comprehensive Sample
⚙️Variables:Autoimmune · Hemolytic anemia · Infectious mononucleosis

Abstract

Infectious mononucleosis (EM) is a disease characterized by irradiation of the Epstein-Barr virus (EBV). The clinical manifestation is characterized by tonsillopharyngitis, lym-phadenopathy and atypical lymphocytosis. We describe a young patient developing hemolytic anemia during follow-up in our clinic due to tonsillopharyngitis secondary to EBV and general condition disorder.

Özet

Enfeksiyöz mononükleoz (EM), Epstein-Barr virüsünün (EBV) yayılması ile karakterize bir hastalıktır. Klinik bul-gular tonsillofarenjit, lenfadenopati ve atipik lenfositoz ile karakterizedir. EBV'ye sekonder tonsillofarenjit ve genel durum bozukluğu nedeniyle kliniğimizde takip sırasında hemolitik anemi gelişen genç bir hastayı tanımladık.

🔖

Cite This Article

İnce, N., Öneç, B. (2020). Autoimmune Hemolytic Anemia Developing Secondary to Epstein-Barr Virus Infection: A case report. Online Türk Sağlık Bilimleri Dergisi, Cilt: 5 Sayı: 1, 199–202. https://doi.org/10.26453/otjhs.637602

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Johannsen EC, Schooley RT, Kaye KM. Epstein-Barr virus (infectious mononucleosis). In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. 6th ed. Vol 2. Philadelphia: Elsevier Churchill Livingstone, 2005:1801-20.
  2. Arman D. Epstein-Barr virüs. Topçu Wilke A, Söyletir G, Doğanay M (editörler). İnfeksiyon Hastalıkları ve Mikrobiyolojisi. 1. Baskı. İstanbul: Nobel Tıp Kitabevleri, 2002:1197-201.
  3. Lennon P, Saunders J, Fenton JE. A longer stay for the kissing disease: epidemiology of bacterial tonsillitis and infectious mononucleosis over a 20- year period. J Laryngol Otol. 2013;7:1-5.
  4. Cohen JI. Treatment of infectious mononucleosis: When and how? The Herpes Monitor. 2003;3:1-5.
  5. Straus SE, Cohen JI, Tosato G, Meier J. Epstein-Barr virus infections: Biology, pathogenesis and management. Ann Intern Med. 1993;118:45-58.
  6. Tynell E, Aurelius E, Brandell A, et al. Acyclovir and prednisolone treatment of acute infectious mononucleosis: A multicenter, double-bind, plasebocontrolled study. J Infect Dis. 1996;174:324-31.
  7. H.B. Jenson. Acute complications of Epstein–Barr virus infectious mononucleosis. Curr Opin Pediatr. 12 (2000), pp. 263-268.
  8. Zanella A, Barcellini W. Treatment of autoimmune hemolytic anemias. Haematologica. 2014:1457-1554.
  9. E. C. Besa, Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders. The American Journal of Medicine. 1988:691-8.
  10. Vouloumanou E.K, Rafailidis P.I, Falagas M.E. Current diagnosis and management of infectious mononucleosis. Curr Opin Hematol. 2012;19(1):14-20.